Pharmacogenetics of CYP450A, ABCB1, ABCC2, SLCO1B3 gene polymorphisms and plasma alpha-1-acid glycoprotein level on nonhaematological adverse events of docetaxel in Malaysian breast cancer patients
Docetaxel is an antitubulin chemotherapeutic agent approved for the treatment of breast, lung, ovarian and non-hormonal dependent prostate cancers. However, the success of this drug is limited by adverse events (AEs), the severity of which ranges from tolerable to life threatening. Tapering the dose...
Saved in:
Main Author: | Jabir, Rafid Salim |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2015
|
Online Access: | http://psasir.upm.edu.my/id/eprint/70717/1/FPSK%28P%29%202017%2034%20IR.pdf http://psasir.upm.edu.my/id/eprint/70717/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plasma alpha-1-acid glycoprotein as a potential predictive biomarker for non-haematological adverse events of docetaxel in breast cancer patients
by: Jabir, Rafid Salim, et al.
Published: (2018) -
A pharmacogenetic study of cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase complex 1 (VKORCl) / Immaculate Mbongo Langmia
by: Mbongo Langmia, Immaculate
Published: (2011) -
Docking of mouse P-glycoprotein (ABCB1a/MDR3) with verapamil and cyclosporine A / Zakiah Salleh
by: Salleh, Zakiah
Published: (2012) -
The Risk of Recurrence in Breast Cancer Patients Treated with Tamoxifen: Polymorphisms of CYP2D6 and ABCB1
by: Teh, L. K., et al.
Published: (2011) -
Docking of mouse p-glycoprotein (ABCB1a/MDR3) with Rhodamine B and Vinblastine / Hazureen Mohd Halimi
by: Mohd Halimi, Hazureen
Published: (2012)